Big Pharma actually listened 🛑 Lisa Bonebrake (Exec. Director of @AlportSyndFndn ) tells host @johnbstanford a major drug developer completely redesigned their clinical trial protocol after hearing directly from rare disease patients. With insights from Janis Naeve, world-class VC and Co-Founder/Partner of Bright Frontier Capital, this @MakingMedPod episode proves patient advocacy drives real medical innovation. 👇 Have you seen patient feedback change industry behavior? Reply below, and watch the full episode here: youtu.be/c4IEWcwpFa8?si=1Rfn… 💊Follow us for critical biotech and healthcare policy coverage #clinicaltrials #patientadvocacy #alportsyndrome #drugdevelopment #pharma @incub8coalition @US_FDA @CDCgov @HHSGov @NIH @WhiteHouse @WHO

More than 2,700 hospitals now participate in the 340B drug pricing program and according to @CCrainNAM of @ShopFloorNAM, it’s growing faster than any other federal healthcare program in the country 📉🏥 Host @johnbstanford sits down with Charles on the latest clip of @MakingMedPod to look at why this massive program is exploding so quickly and what it means for the future of healthcare policy. Watch the full episode here: youtube.com/watch?v=iigOzZP7… #340b #healthcarepolicy #ushospitals #drugpricing #healthcaresystem #biotech

Would you risk hundreds of millions of dollars developing a lifesaving drug if the government could completely change the rules right before you finished? 📉🧪 @CCrainNAM of @ShopFloorNAM joins host @johnbstanford on @MakingMedPod to explain the exact regulatory nightmare facing biotech innovators today when FDA guidelines shift mid-process, derailing investment and stalling new treatments. Full episode: youtube.com/watch?v=iigOzZP7… #biotech #drugdevelopment #fda #medicalinnovation #clinicaltrials #healthcarepolicy

Ever wonder why prescription drugs cost so much at the pharmacy counter, even with health insurance? 🛑💸 On this clip of @MakingMedPod, @CCrainNAM from @ShopFloorNAM joins host @johnbstanford to pull back the curtain on PBMs, the hidden prescription drug middlemen who actually profit when list prices stay high. Listen to the full breakdown here: youtube.com/watch?v=iigOzZP7… #pbmreform #pbm #healthcaremiddlemen #drugpricing #insurance #healthcaresystem

Most people assume prescription drugs are the absolute biggest driver of skyrocketing healthcare costs. But what if they're only 9% of the total? 🤯 On the latest episode of @MakingMedPod, host @johnbstanford sits down with @CCrainNAM from @ShopFloorNAM to look at the real data behind the healthcare system and bust the biggest myth in medicine. Watch the full episode here: youtube.com/watch?v=iigOzZP7… #healthcare #drugpricing #bigpharma #healthcaresystem #medicalbills #biotech

Great to join @johnbstanford on the @MakingMedPod to talk about how to drive American innovation and make healthcare more affordable for manufacturers and their workers.  📻Tune in to hear how PBM reform, 340B transparency, and continued regulatory certainty from the FDA will keep the workforce at full strength while lowering the cost of healthcare. youtube.com/watch?v=iigOzZP7…

Many Americans are discovering that paying cash for medicine can sometimes cost less than using insurance. 💊 John Stanford joined the Brian Kilmeade show to discuss Trump RX, healthcare affordability, PBMs, and why patients continue to face barriers accessing prescribed medicines. Follow us for critical biotech and healthcare policy coverage 🎙️ Full interview at the link in bio #Healthcare #DrugPricing @johnbstanford @kilmeade @FoxNews @foxnewsradio @incub8coalition @US_FDA @HHSGov @NIH @WhiteHouse @MedicineMa80739

We should be aggressively courting brainpower from around the world. Scientific talent may become one of the defining factors in biotech competitiveness over the next decade 🧠 Follow us for critical biotech and healthcare policy coverage 🎙️ Full episode at the link in bio @johnbstanford @incub8coalition @RepScottPeters @US_FDA @HHSGov @WhiteHouse @realDonaldTrump #biotech #innovation

The “pill penalty” debate wasn’t just about drug pricing, it was about future biotech investment and innovation incentives. 💊 Will policies tied to Medicare negotiation change what types of medicines companies pursue? Follow us for critical biotech and healthcare policy coverage 🎙️ Full episode at the link in bio @johnbstanford @incub8coalition @RepScottPeters @US_FDA @HHSGov #biotech #drugpricing #congress

They’ve read our playbook and they’re doing a pretty good job. China’s biotech growth is becoming one of the biggest strategic conversations in healthcare and innovation policy 🧬🇨🇳 Follow us for critical biotech and healthcare policy coverage 🎙️ Full episode at the link in bio @johnbstanford @incub8coalition @RepScottPeters @US_FDA @HHSGov #biotech #china

In the newest @MakingMedPod, @johnbstanford sits down with @jefakst of @biospace to unpack FDA reversals, the Moderna mRNA flu vaccine decision, biotech investment risk, and Most Favored Nation drug pricing policy. We break down regulatory uncertainty at the @FDA, vaccine investment challenges, Alzheimer’s drug development, and the rise of psychedelics in mental health treatment. We also discuss new polling showing Americans are more concerned with overall affordability, like groceries, housing, and health insurance, than with lowering prescription drug prices. Watch the full episode on YouTube: youtu.be/fRWtrAEhWN4?si=Pd5j… #FDA #Biotech #DrugPricing #Pharmaceuticals #HealthcarePolicy

John Stanford explains why they want high prices: they keep half the profit. The math on your prescription doesn't add up, and it’s not an accident. It’s a business model. 📉 Watch the full episode at the link in our bio

John Stanford explains why they want high prices: they keep half the profit. The math on your prescription doesn't add up, and it’s not an accident. It’s a business model. 📉 Watch the full episode at the link in our bio

John Stanford reveals the FDA is skipping Congress to approve drugs in months, not years. Staff are revolting, claiming it breaks scientific norms. Is this necessary innovation or a safety disaster waiting to happen? ⚖️ Watch the full episode at the link in our bio.

In the newest @MakingMedPod, @johnbstanford breaks down the biggest biotech stories of 2025 -- from national security priorities and venture funding shifts to AI-driven drug development, FDA approvals, and PBM reform efforts. Full episode on YouTube: youtube.com/watch?v=oaS0RUQ7…

Last month, @SenThomTillis joined @JohnBStanford for @MakingMedPod -- warning that foreign free-riding harms American life sciences. Give the episode a listen: buff.ly/Iy1CrJD